Animal models in the drug discovery pipeline for Alzheimer's disease
暂无分享,去创建一个
[1] M. Lardelli,et al. Developmental control of Presenilin1 expression, endoproteolysis, and interaction in zebrafish embryos. , 2003, Experimental cell research.
[2] Iva Greenwald,et al. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene , 1995, Nature.
[3] I. Ferrer,et al. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice , 2005, Neurobiology of Disease.
[4] P. Shaw,et al. Cryptotanshinone, an acetylcholinesterase inhibitor from Salvia miltiorrhiza, ameliorates scopolamine-induced amnesia in Morris water maze task. , 2010, Planta medica.
[5] P. Whitehouse,et al. Cholinergic receptors in aging and Alzheimer's disease , 1986, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[6] M. Pallàs,et al. Neuroprotective role of intermittent fasting in senescence-accelerated mice P8 (SAMP8) , 2010, Experimental Gerontology.
[7] M. Lardelli,et al. Identification of a second presenilin gene in zebrafish with similarity to the human Alzheimer's disease gene presenilin2 , 2002, Development Genes and Evolution.
[8] F. LaFerla,et al. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer’s disease , 2003, Neurobiology of Aging.
[9] S D Rogers,et al. Fibrillar b-Amyloid Induces Microglial Phagocytosis , Expression of Inducible Nitric Oxide Synthase , and Loss of a Select Population of Neurons in the Rat CNS In Vivo , 1998 .
[10] M. Mattson,et al. Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.
[11] P. Davies,et al. SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE , 1976, The Lancet.
[12] T. Takeda. Senescence-accelerated mouse (SAM): a biogerontological resource in aging research , 1999, Neurobiology of Aging.
[13] T. Nabeshima,et al. Memory impairment induced by chronic intracerebroventricular infusion of beta-amyloid (1–40) involves downregulation of protein kinase C , 2002, Brain Research.
[14] D. Butterfield,et al. The antioxidants α‐lipoic acid and N‐acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice , 2003, Journal of neurochemistry.
[15] D. Butterfield,et al. Antisense directed at the Abeta region of APP decreases brain oxidative markers in aged senescence accelerated mice. , 2004, Brain research.
[16] P. Deyn,et al. Animal Models of Dementia , 2011, Neuromethods.
[17] I. Greenwald,et al. HOP-1, a Caenorhabditis elegans presenilin, appears to be functionally redundant with SEL-12 presenilin and to facilitate LIN-12 and GLP-1 signaling. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[18] M. Mesulam,et al. Central cholinergic pathways in the rat: An overview based on an alternative nomenclature (Ch1–Ch6) , 1983, Neuroscience.
[19] B. Winblad,et al. The role of nicotinic receptors in the pathophysiology of Alzheimer's disease. , 1989, Progress in brain research.
[20] M. Mesulam,et al. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. , 1998, Brain : a journal of neurology.
[21] R. Martins,et al. Interference with splicing of Presenilin transcripts has potent dominant negative effects on Presenilin activity. , 2008, Human molecular genetics.
[22] Joshua M. Shulman,et al. Tauopathy in Drosophila: Neurodegeneration Without Neurofibrillary Tangles , 2001, Science.
[23] K. Kendrick,et al. Biochemical and neurobehavioral profile of CHF2819, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease. , 2000, The Journal of pharmacology and experimental therapeutics.
[24] Nancy Hopkins,et al. Mutagenesis strategies in zebrafish for identifying genes involved in development and disease. , 2006, Trends in genetics : TIG.
[25] C. Geula,et al. Distribution, progression and chemical composition of cortical amyloid-β deposits in aged rhesus monkeys: similarities to the human , 2003, Acta Neuropathologica.
[26] K. White,et al. Identification, secretion, and neural expression of APPL, a Drosophila protein similar to human amyloid protein precursor , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[27] Y. Christen,et al. Amyloid-β-Induced Pathological Behaviors Are Suppressed by Ginkgo biloba Extract EGb 761 and Ginkgolides in Transgenic Caenorhabditis elegans , 2006, The Journal of Neuroscience.
[28] Brian J Cummings,et al. The canine as an animal model of human aging and dementia , 1996, Neurobiology of Aging.
[29] H. Geerts. Pharmacological Validation in Animal Models of Dementia , 2011 .
[30] S. Younkin,et al. Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.
[31] K. Rangappa,et al. Muscarinic receptor 1 agonist activity of novel N-arylthioureas substituted 3-morpholino arecoline derivatives in Alzheimer's presenile dementia models. , 2008, Bioorganic & medicinal chemistry.
[32] W. Markesbery,et al. Carboxy terminal of β-amyloid deposits in aged human, canine, and polar bear brains , 1996, Neurobiology of Aging.
[33] J Korf,et al. β‐Amyloid neurotoxicity is mediated by a glutamate‐triggered excitotoxic cascade in rat nucleus basalis , 2000, The European journal of neuroscience.
[34] T. Ahmed,et al. Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer's disease , 2009, Pharmacology Biochemistry and Behavior.
[35] C. Morissette,et al. Targeting soluble Aβ peptide with Tramiprosate for the treatment of brain amyloidosis , 2007, Neurobiology of Aging.
[36] J. Coyle,et al. Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis , 1981, Annals of neurology.
[37] Linus Jönsson,et al. The worldwide societal costs of dementia: Estimates for 2009 , 2010, Alzheimer's & Dementia.
[38] M. Voytko,et al. Cognitive function and its neural mechanisms in nonhuman primate models of aging, Alzheimer disease, and menopause. , 2004, Frontiers in bioscience : a journal and virtual library.
[39] Jason Eriksen,et al. A decade of modeling Alzheimer's disease in transgenic mice. , 2006, Trends in genetics : TIG.
[40] Stephen T. C. Wong,et al. Zebrafish lacking Alzheimer presenilin enhancer 2 (Pen‐2) demonstrate excessive p53‐dependent apoptosis and neuronal loss , 2006, Journal of neurochemistry.
[41] C. Cotman,et al. β-Amyloid deposition and tau phosphorylation in clinically characterized aged cats , 2005, Neurobiology of Aging.
[42] B. Winblad,et al. The Magnitude of Dementia Occurrence in the World , 2003, Alzheimer disease and associated disorders.
[43] B. Sommer,et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[44] M. Staufenbiel,et al. APP23 Mice as a Model of Alzheimer's Disease: An Example of a Transgenic Approach to Modeling a CNS Disorder , 2005, CNS Spectrums.
[45] C. Barnes,et al. The neurobiology of memory changes in normal aging , 2003, Experimental Gerontology.
[46] D. Mumby,et al. Perirhinal cortex lesions produce variable patterns of retrograde amnesia in rats , 2003, Behavioural Brain Research.
[47] D. Price,et al. Neurofibrillary Tangles and Senile Plaques in Aged Bears , 1988, Journal of neuropathology and experimental neurology.
[48] G. Yen,et al. Antioxidant and cognitive promotion effects of anthocyanin-rich mulberry (Morus atropurpurea L.) on senescence-accelerated mice and prevention of Alzheimer's disease. , 2010, The Journal of nutritional biochemistry.
[49] L. Buée,et al. Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology. , 2010, Journal of Alzheimer's disease : JAD.
[50] K. Davis,et al. Neurochemical Correlates of Dementia Severity in Alzheimer's Disease: Relative Importance of the Cholinergic Deficits , 1995, Journal of neurochemistry.
[51] D. Stein,et al. Differences in memory impairment and response to GM1 ganglioside treatment following electrolytic or ibotenic acid lesions of the nucleus basalis magnocellularis. , 1999, Restorative neurology and neuroscience.
[52] A. Fire,et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.
[53] S H Ferris,et al. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. , 1987, The Journal of clinical psychiatry.
[54] Diederick E Grobbee,et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study , 1995, BMJ.
[55] G. Wenk,et al. The toxicity of tumor necrosis factor-α upon cholinergic neurons within the nucleus basalis and the role of norepinephrine in the regulation of inflammation: implications for alzheimer's disease , 2003, Neuroscience.
[56] M. Brand,et al. Zebrafish (Danio rerio) presenilin promotes aberrant amyloid beta-peptide production and requires a critical aspartate residue for its function in amyloidogenesis. , 1999, Biochemistry.
[57] K. Jishage,et al. Depletion of Vitamin E Increases Amyloid β Accumulation by Decreasing Its Clearances from Brain and Blood in a Mouse Model of Alzheimer Disease* , 2009, The Journal of Biological Chemistry.
[58] Elizabeth Head,et al. The canine (dog) model of human aging and disease: dietary, environmental and immunotherapy approaches. , 2008, Journal of Alzheimer's disease : JAD.
[59] Y Chen,et al. Nerve growth factor promotes collateral sprouting of cholinergic fibers in the septohippocampal cholinergic system of aged rats with fimbria transection. , 1992, Brain research.
[60] H. Tanila,et al. Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease , 2010, Journal of Neuroinflammation.
[61] I. Nishimoto,et al. Implanted cannula-mediated repetitive administration of Aβ25–35 into the mouse cerebral ventricle effectively impairs spatial working memory , 2005, Behavioural Brain Research.
[62] P. D. De Deyn,et al. Drug discovery in dementia: the role of rodent models. , 2006, Nature reviews. Drug discovery.
[63] T. Ishrat,et al. Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT) , 2009, European Neuropsychopharmacology.
[64] A. Toledano,et al. Lesion-Induced Vertebrate Models of Alzheimer Dementia , 2011 .
[65] Andrew M. Petzold,et al. A primer for morpholino use in zebrafish. , 2009, Zebrafish.
[66] R. Conlon,et al. Transgenic and Gene Targeted Models of Dementia , 2011 .
[67] T. Robbins,et al. Selective lesions of the dorsomedial striatum impair serial spatial reversal learning in rats , 2010, Behavioural Brain Research.
[68] Thomas Steckler,et al. Cholinergic blockade impairs performance in operant DNMTP in two inbred strains of mice , 2002, Pharmacology Biochemistry and Behavior.
[69] L Byerly,et al. The life cycle of the nematode Caenorhabditis elegans. II. A simplified method for mutant characterization. , 1976, Developmental biology.
[70] H. Nakayama,et al. Senile Plaques and Other Senile Changes in the Brain of an Aged American Black Bear , 1995, Veterinary pathology.
[71] Y. Nomura,et al. Antioxidative activity and ameliorative effects of memory impairment of sulfur‐containing compounds in Allium species , 2006, BioFactors.
[72] R. Penn,et al. Cortical Biopsy Results in Alzheimer Disease: Correlation with Cognitive Deficits , 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[73] C. Masters,et al. Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial Aβ , 2008, Neuron.
[74] D. K. Rush,et al. Scopolamine amnesia of passive avoidance: a deficit of information acquisition. , 1988, Behavioral and neural biology.
[75] W. Banks,et al. Delivery across the blood-brain barrier of antisense directed against amyloid beta: reversal of learning and memory deficits in mice overexpressing amyloid precursor protein. , 2001, The Journal of pharmacology and experimental therapeutics.
[76] M. Konsolaki,et al. A model for studying Alzheimer's Aβ42-induced toxicity in Drosophila melanogaster , 2004, Molecular and Cellular Neuroscience.
[77] D. Van Dam,et al. Ibuprofen modifies cognitive disease progression in an Alzheimer’s mouse model , 2010, Journal of psychopharmacology.
[78] L. Mucke,et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.
[79] B T Hyman,et al. Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[80] R. Tanzi,et al. Isolation and characterization of the Drosophila ubiquilin ortholog dUbqln: in vivo interaction with early-onset Alzheimer disease genes. , 2007, Human molecular genetics.
[81] W. Banks,et al. Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice , 2000, Peptides.
[82] R. Nitsch,et al. Age-Dependent Neurodegeneration and Alzheimer-Amyloid Plaque Formation in Transgenic Drosophila , 2004, The Journal of Neuroscience.
[83] D. Amaral,et al. Cholinergic innervation of the primate hippocampal formation: II. Effects of fimbria/fornix transection , 1996, The Journal of comparative neurology.
[84] Arie Johannes Van Der Spek,et al. Cognitive disturbances in old dogs suffering from the canine counterpart of Alzheimer's disease , 2006, Brain Research.
[85] H. Annoura,et al. Progressive brain dysfunction following intracerebroventricular infusion of beta1–42-amyloid peptide , 2001, Brain Research.
[86] C. Link,et al. Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[87] G. J. Cole,et al. Generation of transgenic zebrafish expressing green fluorescent protein under control of zebrafish amyloid precursor protein gene regulatory elements. , 2007, Zebrafish.
[88] J. Glorioso,et al. Herpes simplex virus RNAi and neprilysin gene transfer vectors reduce accumulation of Alzheimer's disease-related amyloid-beta peptide in vivo. , 2006, Gene therapy.
[89] C. Parsons,et al. Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice. , 2010, The American journal of pathology.
[90] Hans Lehrach,et al. Distinct expression patterns of two zebrafish homologues of the human APP gene during embryonic development , 2001, Development Genes and Evolution.
[91] T. Golde,et al. Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal Aβ levels , 2007, Molecular Neurodegeneration.
[92] D. Butterfield,et al. Spontaneous Vertebrate Models of Alzheimer Dementia: Selectively Bred Strains (SAM Strains) , 2011 .
[93] K. White,et al. A Drosophila gene encoding a protein resembling the human beta-amyloid protein precursor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[94] P. Deyn,et al. Validation of the APP23 Transgenic Mouse Model of Alzheimer’s Disease through Evaluation of Risperidone Treatment on Aggressive Behaviour , 2008, Arzneimittel-Forschung (Drug Research).
[95] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[96] N. Hukriede,et al. Generation of a transgenic zebrafish model of Tauopathy using a novel promoter element derived from the zebrafish eno2 gene , 2007, Nucleic acids research.
[97] D. Butterfield,et al. Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders , 2005, Neurochemistry International.
[98] C. Li,et al. apl-1, a Caenorhabditis elegans gene encoding a protein related to the human beta-amyloid protein precursor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[99] M. Giannakou,et al. Drosophila Melanogaster as a Model Organism for Dementia , 2011 .
[100] T. Ahmed,et al. Curcuminoids enhance memory in an amyloid-infused rat model of Alzheimer's disease , 2010, Neuroscience.
[101] J. Götz,et al. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models , 2004, International Journal of Developmental Neuroscience.
[102] C. Finch,et al. Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[103] D. Selkoe,et al. Toward a Comprehensive Theory for Alzheimer's Disease. Hypothesis: Alzheimer's Disease Is Caused by the Cerebral Accumulation and Cytotoxicity of Amyloid β‐Protein , 2000, Annals of the New York Academy of Sciences.
[104] G. Cole,et al. Rodent models of Alzheimer's disease: Rat aβ infusion approaches to amyloid deposits , 1996, Neurobiology of Aging.
[105] S. Engelborghs,et al. Altered circadian locomotor activity in APP23 mice: a model for BPSD disturbances , 2004, The European journal of neuroscience.
[106] J. Mulder,et al. Galantamine-induced behavioral recovery after sublethal excitotoxic lesions to the rat medial septum , 2005, Behavioural Brain Research.
[107] E. Sipos,et al. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease. , 2007, Neuroscience.
[108] A. Fagan,et al. Cerebral amyloid-beta protein accumulation with aging in cotton-top tamarins: a model of early Alzheimer's disease? , 2008, Rejuvenation research.
[109] S. Paul,et al. Raloxifene and estradiol benzoate both fully restore hippocampal choline acetyltransferase activity in ovariectomized rats , 1999, Brain Research.
[110] Shuo Lin,et al. Characterization and development of novel small-molecules inhibiting GSK3 and activating Wnt signaling. , 2009, Molecular bioSystems.
[111] Adam James Waite,et al. An improved zinc-finger nuclease architecture for highly specific genome editing , 2007, Nature Biotechnology.
[112] Akihiko Takashima,et al. Age-related changes of Alzheimer's disease-associated proteins in cynomolgus monkey brains. , 2003, Biochemical and biophysical research communications.
[113] C. Geula,et al. Amyloid-beta deposits in the cerebral cortex of the aged common marmoset (Callithrix jacchus): incidence and chemical composition. , 2002, Acta neuropathologica.
[114] D. Westaway,et al. Cyclohexanehexol inhibitors of Aβ aggregation prevent and reverse Alzheimer phenotype in a mouse model , 2006, Nature Medicine.
[115] R. Nadal,et al. Electrolytic and ibotenic acid lesions of the nucleus basalis magnocellularis interrupt long-term retention, but not acquisition of two-way active avoidance, in rats , 2001, Experimental Brain Research.
[116] N. Munakata. [Genetics of Caenorhabditis elegans]. , 1989, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[117] Mark A Lane,et al. Nonhuman primate models in biogerontology , 2000, Experimental Gerontology.
[118] F. LaFerla,et al. The 3xTg-AD Mouse Model: Reproducing and Modulating Plaque and Tangle Pathology , 2011 .
[119] D. Butterfield,et al. The senescence-accelerated prone mouse (SAMP8): A model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease , 2005, Experimental Gerontology.
[120] L. Byerly,et al. The life cycle of the nematode Caenorhabditis elegans. I. Wild-type growth and reproduction. , 1976, Developmental biology.
[121] T. Harkany,et al. induces behavioral dysfunctions, impairs learning and memory and disrupts cortical cholinergic innervation , 1998 .
[122] C. Link. C. elegans models of age-associated neurodegenerative diseases: Lessons from transgenic worm models of Alzheimer’s disease , 2006, Experimental Gerontology.
[123] O. Touloumi,et al. Statins Reduce the Neurofibrillary Tangle Burden in a Mouse Model of Tauopathy , 2009, Journal of neuropathology and experimental neurology.
[124] J. Tigges,et al. β-Amyloid (Aβ) Deposition in the Brains of Aged Orangutans , 1997, Neurobiology of Aging.
[125] D. Selkoe,et al. Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervet. , 2004, The American journal of pathology.
[126] D. Selkoe,et al. Aβ Oligomers – a decade of discovery , 2007, Journal of neurochemistry.
[127] H. Braak,et al. Abnormally phosphorylated tau protein related to the formation of neurofibrillary tangles and neuropil threads in the cerebral cortex of sheep and goat , 1994, Neuroscience Letters.
[128] B. de Strooper,et al. 1-(3′,4′-Dichloro-2-fluoro[1,1′-biphenyl]-4-yl)-cyclopropanecarboxylic Acid (CHF5074), a Novel γ-Secretase Modulator, Reduces Brain β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease without Causing Peripheral Toxicity , 2007, Journal of Pharmacology and Experimental Therapeutics.
[129] P. Moran,et al. Differential effects of scopolamine and mecamylamine on working and reference memory in the rat , 1993, Pharmacology Biochemistry and Behavior.
[130] H. Geerts. Bridging the Translational Disconnect in CNS Drug Discovery , 2009 .
[131] R. Urbanics,et al. A chronic Alzheimer’s model evoked by mitochondrial poison sodium azide for pharmacological investigations , 2004, Behavioural Brain Research.
[132] Bin Zhang,et al. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[133] N. McNaughton,et al. Comparison between the behavioural effects of septal and hippocampal lesions: A review , 1983, Neuroscience & Biobehavioral Reviews.
[134] F. Tang,et al. Reduction in somatostatin and substance P levels and choline acetyltransferase activity in the cortex and hippocampus of the rat after chronic intracerebroventricular infusion of β-amyloid (1-40) , 1999, Brain Research Bulletin.
[135] M. Good,et al. Double dissociation between hippocampal and prefrontal lesions on an operant delayed matching task and a water maze reference memory task , 2006, Behavioural Brain Research.
[136] J. Sirviö,et al. Effects of concurrent manipulations of nicotinic and muscarinic receptors on spatial and passive avoidance learning , 1990, Pharmacology Biochemistry and Behavior.
[137] R. Hampson,et al. Mechanisms underlying cognitive enhancement and reversal of cognitive deficits in nonhuman primates by the ampakine CX717 , 2008, Psychopharmacology.
[138] S. Hellberg,et al. A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation. , 2009, The Journal of clinical investigation.
[139] J. Hauw,et al. Differential correlation between neurochemical deficits, neuropathology, and cognitive status in Alzheimer's disease , 1995, Neurobiology of Aging.
[140] P. Adlard,et al. The cause of neuronal degeneration in Alzheimer's disease , 2000, Progress in Neurobiology.
[141] Ichiro Akiguchi,et al. Age-related deterioration of ability of acquisition in memory and learning in senescence accelerated mouse: SAM-P/8 as an animal model of disturbances in recent memory , 1988, Brain Research.
[142] Brian J Cummings,et al. Beta-amyloid accumulation in aged canine brain: a model of early plaque formation in Alzheimer's disease. , 1993, Neurobiology of aging.
[143] J. Shulman,et al. Genetic modifiers of tauopathy in Drosophila. , 2003, Genetics.
[144] E. Head,et al. Ageing changes in cat brains demonstrated by β-amyloid and AT8-immunoreactive phosphorylated tau deposits , 2006, Journal of feline medicine and surgery.
[145] Ann-Shyn Chiang,et al. Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[146] J. Wood,et al. Transgenic zebrafish model of neurodegeneration , 2002, Journal of neuroscience research.
[147] J. Trojanowski,et al. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. , 2010, Archives of neurology.
[148] C. Finch,et al. Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers , 2004, The Journal of Neuroscience.
[149] L. Butcher,et al. Characterization of the cognitive effects of combined muscarinic and nicotinic blockade. , 1990, Behavioral and neural biology.
[150] P. Lawlor,et al. Aβ Infusion and Related Models of Alzheimer Dementia , 2011 .
[151] Kenneth H. Johnson,et al. Aβ-Associated cerebral angiopathy and senile plaques with neurofibrillary tangles and cerebral hemorrhage in an aged wolverine (Gulo gulo) , 1996, Neurobiology of Aging.
[152] P. Dobrzanski,et al. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease , 1998, Brain Research.
[153] M. Staufenbiel,et al. Aggressive male APP23 mice modeling behavioral alterations in dementia. , 2006, Behavioral neuroscience.
[154] P. May,et al. P2-053 Reduced β-amyloid burden, increased C-99 concentrations and evaluation of neuropathology in the brains of PDAPP mice given LY450139 dihydrate daily by gavage for 5 months , 2004, Neurobiology of Aging.
[155] C. Moens,et al. Reverse genetics in zebrafish by TILLING. , 2008, Briefings in functional genomics & proteomics.
[156] D. Selkoe,et al. Identification of amyloid beta protein in the brain of the small, short-lived Lemurian primate Microcebus murinus , 1994, Neurobiology of Aging.
[157] J. Ieni,et al. The anti‐amnesic and neuroprotective effects of donepezil against amyloid β25‐35 peptide‐induced toxicity in mice involve an interaction with the σ1 receptor , 2006, British journal of pharmacology.
[158] D. Geschwind,et al. Human Wild-Type Tau Interacts with wingless Pathway Components and Produces Neurofibrillary Pathology in Drosophila , 2002, Neuron.
[159] P. Tariot,et al. Pharmacologic modelling of Alzheimer's disease , 1986, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[160] Stephen T. C. Wong,et al. Phenotypic analysis of images of zebrafish treated with Alzheimer's γ-secretase inhibitors , 2010, BMC biotechnology.
[161] W. Banks,et al. Nitric oxide activity and isoenzyme expression in the senescence-accelerated mouse p8 model of Alzheimer's disease: effects of anti-amyloid antibody and antisense treatments. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.